Filing Flows › Health Care › Escalon Medical (ESMC)
Escalon Medical (ESMC) earnings and revenue breakdown
Latest: Q4 FY26 · 10-K filed Oct 13, 2026 · Escalon Medical (ESMC) Q4 FY26 earnings results →
Q4 FY26 Revenue up 50% year over year to $3.9M · 46¢ of every $1 of revenue kept as net profit · operating margin 14.7%
Escalon Medical made $3.9M in Q4 FY26 (+50% Y/Y): Product $3.7M, Service $202K. Operating margin 14.7%, net earnings $1.8M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-K filed Oct 13, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $3.9M in Q4 FY26, up 50% year over year and up 48% from the previous quarter. Product was the largest line at 95% of revenue.
Operating profit was $569K, a 14.7% margin (up 29.2 points year over year). Total costs grew 12% against revenue growth of 50%. The fastest-growing cost line was Cost of revenue (+32%). Net earnings were $1.8M. The tax line was a benefit of $1.1M on pre-tax earnings of $642K.
Operating cash flow was −$251K. Non-cash charges added back $3K of depreciation and amortization. Working capital and other items used $2.0M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q4 FY26 | 10-K | Oct 13, 2026 | $3.9M | +50% | 14.7% | $1.8M | −$251K |
| Q3 FY26 | 10-Q | May 15, 2026 | $2.6M | -25% | -16.1% | $2.4M | $281K |
| Q2 FY26 | 10-Q | Feb 17, 2026 | $3.6M | +12% | 2.7% | $98K | −$517K |
| Q1 FY26 | 10-Q | Nov 14, 2025 | $2.7M | -4% | -7.6% | −$240K | $85K |
| Q4 FY25 | 10-K | Sep 29, 2025 | $2.6M | -26% | -14.5% | −$380K | $16K |
| Q3 FY25 | 10-Q | May 14, 2025 | $3.5M | +29% | 7.9% | $271K | $31K |
| Q2 FY25 | 10-Q | Feb 14, 2025 | $3.2M | +12% | 7.9% | $246K | $301K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Escalon Medical
Escalon Medical Corp. ("Escalon" or "Company") is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the “Company” collectively shall mean Escalon, which includes its division called "Trek" and its wholly owned subsidiaries: Sonomed, Inc. (“Sonomed”), Escalon Digital Solutions, Inc. (“EMI”), and Sonomed IP Holdings, Inc. All intercompany accounts and transactions have been eliminated. The Company operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices for ophthalmic applications. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration (the “FDA”).
In its own words, from its 10-K, filed Oct 13, 2026.
Escalon Medical against its Electromedical & Electrotherapeutic Apparatus peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +50% against the peers' median +14%. Operating margin: 14.7% against the peers' median 7.2%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ESMC Escalon Medical | Q4 FY26 | $3.9M | +50% | 14.7% |
| MDT Medtronic | Q1 FY27 | $9.8B | +14% | 18.1% |
| ITGR Integer Holdings | Q3 2026 | $450M | -4% | 6.3% |
| LIVN LivaNova | Q3 2026 | $393M | +10% | 7.2% |
| CNMD Conmed | Q3 2026 | $336M | -0.7% | 11.1% |
| TMDX TransMedics Group | Q3 2026 | $203M | +41% | 13.9% |
| AXGN Axogen | Q3 2026 | $75.8M | +26% | 1.3% |
| OM Outset Medical | Q3 2026 | $33.6M | +14% | -36.5% |
| CBLL Ceribell | Q3 2026 | $29.3M | +30% | -70.0% |
Source: Escalon Medical 10-K on SEC EDGAR · CIK 862668 · Electromedical & Electrotherapeutic Apparatus
More on ESMC
History
Every quarter: Q4 FY26 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results · Q2 FY25 results